메뉴 건너뛰기




Volumn 33, Issue 4, 2013, Pages

Vemurafenib-associated pancreatitis: Case report

Author keywords

Adverse drug reactions; Drug safety; Gastroenterology; Melanoma; Oncology

Indexed keywords

B RAF KINASE; INTERLEUKIN 2; IPILIMUMAB; TRIACYLGLYCEROL LIPASE; VEMURAFENIB;

EID: 84879517351     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1208     Document Type: Article
Times cited : (11)

References (11)
  • 1
    • 79959795786 scopus 로고    scopus 로고
    • Improved survival with vemurafenib in melanoma with BRAF V600E mutation
    • Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364:2507-2516.
    • (2011) N Engl J Med , vol.364 , pp. 2507-2516
    • Chapman, P.B.1    Hauschild, A.2    Robert, C.3
  • 3
    • 77953665094 scopus 로고    scopus 로고
    • Tyrosine kinase inhibitors and acute pancreatitis
    • Pezzilli R, Corinaldesi R, Morselli-Labate AM. Tyrosine kinase inhibitors and acute pancreatitis. JOP 2010;11:291-293.
    • (2010) JOP , vol.11 , pp. 291-293
    • Pezzilli, R.1    Corinaldesi, R.2    Morselli-Labate, A.M.3
  • 7
    • 78751471040 scopus 로고    scopus 로고
    • Oxaliplatin-induced pancreatitis: A case series
    • Butt W, Saadati H, Saif MW. Oxaliplatin-induced pancreatitis: a case series. Anticancer Res 2010;12:5113-5115.
    • (2010) Anticancer Res , vol.12 , pp. 5113-5115
    • Butt, W.1    Saadati, H.2    Saif, M.W.3
  • 10
  • 11
    • 0019799332 scopus 로고
    • A method for estimating the probability of adverse drug reactions
    • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.
    • (1981) Clin Pharmacol Ther , vol.30 , pp. 239-245
    • Naranjo, C.A.1    Busto, U.2    Sellers, E.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.